Skip to main content
Log in

Tandospirone in the Treatment of Generalised Anxiety Disorder and Mixed Anxiety-Depression

Results of a Comparatively High Dosage Trial

  • Short Communication
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Fig. 2

References

  1. Williams RB. Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other medical disorders? J Psychiatry Res 1990; 24: 51–6

    Article  Google Scholar 

  2. Yamawaki S. The use and development of anxiolytics in Japan. Eur Neuropsychopharmacol 1999; 9: S413–9

    Article  PubMed  CAS  Google Scholar 

  3. Feighner JP, Merideth CH, Hendrickson GA. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. J Clin Psychiatry 1982; 43: 103–7

    PubMed  CAS  Google Scholar 

  4. Lucki I, Rickels K, Giesecke MA, et al. Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. Br J Clin Pharmacol 1987; 23: 207–11

    Article  PubMed  CAS  Google Scholar 

  5. Murphy SM, Owen RT, Tyrer PJ. Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks’ treatment with diazepam or buspirone. Br J Psychiatry 1989; 154: 529–34

    Article  PubMed  CAS  Google Scholar 

  6. Jacobson AF, Dominguez RA, Goldstein BJ, et al. Comparison of buspirone and diazepam in generalized anxiety disorder. Pharmacotherapy 1985; 5: 290–6

    PubMed  CAS  Google Scholar 

  7. Hamik A, Oksenberg G, Fischette C, et al. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites. Biol Psychiatry 1990; 28: 99–109

    Article  PubMed  CAS  Google Scholar 

  8. Tanaka H, Shimizu H, Kumasaka Y, et al. Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain. Brain Res 1991; 546: 181–9

    Article  PubMed  CAS  Google Scholar 

  9. Suzuki M, Uchiumi M, Murasaki M. Effects of tandospirone, a 5-HT1a receptor related anxiolytic, on daytime sleepiness and psychomotor functions: a comparative double-blind study with diazepam. Jpn J Psychopharmacol 1993; 13: 213–24

    CAS  Google Scholar 

  10. Evance SM, Troisi JR, Griffiths RR. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans. J Pharmacol Exp Ther 1994; 271: 683–94

    Google Scholar 

  11. Murasaki M, Mori A, Endo S, et al. Efficacy of a new anxiolytic, tandospirone (SM-3997) on neurosis: a comparative double-blind study with diazepam [in Japanese with abstract in English]. Clin Eval 1992; 20: 295–329

    Google Scholar 

  12. Sumiyoshi T, Matsui M, Yamashita I, et al. The effect of tandospirone, a serotonin1A agonist, on memory function in schizophrenia. Biol Psychiatry 2001; 49: 861–8

    Article  PubMed  CAS  Google Scholar 

  13. Oshima T, Kasuya Y, Terazawa E, et al. The anxiolytic effects of the 5-hydroxytryptamine-1A agonist tandospirone before otolaryngologic surgery. Anesth Analg 2001; 93: 1214–6

    Article  PubMed  CAS  Google Scholar 

  14. American Psychiatric Association. Diagnosis and statistical manual of mental disorders, fourth ed. Washington DC: American Psychiatric Association, 1994

    Google Scholar 

  15. Zinbarg RE, Barlow DH, Liebowitz M, et al. The DSM-IV field trial for mixed anxiety-depression. Am J Psychiatry 1994; 151: 1153–62

    PubMed  CAS  Google Scholar 

  16. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50–5

    Article  PubMed  CAS  Google Scholar 

  17. Stahl SM. Classical antidepressants, serotonin selective reuptake inhibitors and noradrenergic reuptake inhibitors. In: Essential psychopharmacology: neuroscientific basis and practical applications. 2nd ed. Cambridge: Cambridge University Press, 2000: 199–243

  18. Rickels K, Zaninelli R, McCafferty J, et al. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2003; 160: 749–56

    Article  PubMed  Google Scholar 

  19. Rickels K, Weisman K, Norstad N, et al. Buspirone and diazepam in anxiety: a controlled study. J Clin Psychiatry 1982; 43: 81–6

    PubMed  CAS  Google Scholar 

  20. Newton RE, Casten GP, Alms DR, et al. The side effect profile of buspirone in comparison to active controls and placebo. J Clin Psychiatry 1982; 43: 100–2

    PubMed  CAS  Google Scholar 

  21. Wittchen H-U, Zhao S, Kessler R, et al. DSM-III-R generalized anxiety disorder in the national co-morbidity survey. Arch Gen Psychiatry 1994; 51: 355–64

    Article  PubMed  CAS  Google Scholar 

  22. Joffe RT, Schuller DR. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 1993; 54: 269–71

    PubMed  CAS  Google Scholar 

  23. Dimitriou EC, Dimitriou CE. Buspirone augmentation of antidepressant therapy. J Clin Psychopharmacol 1998; 18: 465–9

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Ms Naoko Kinukawa, Department of Medical Information Science, and Ms Kayoko Yamamoto, Department of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan, for discussions and comments. There was no external funding for this study, and the authors have no conflicts of interest directly relevant to the content of this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Mine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishitsuji, K., To, H., Murakami, Y. et al. Tandospirone in the Treatment of Generalised Anxiety Disorder and Mixed Anxiety-Depression. Clin. Drug Investig. 24, 121–126 (2004). https://doi.org/10.2165/00044011-200424020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200424020-00007

Keywords

Navigation